Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD.
Contemporary clinical trials communications June 1, 2025 Daniel Kriegman, Rachel Pelletier, Caroline Griggs et al.
A 4-week treatment protocol incorporating Orgasmic Meditation (OM), a structured attention training practice involving 15 minutes of gentle clitoral stroking, was tested for safety and efficacy in 28 participants (14 pairs) in Massachusetts, 23 of whom had PTSD symptoms (PCL-5 scores >31). Participants performed OM at least 12 times and attended weekly safety check-ins. PTSD scores improved by 47%, with the average score dropping from 60 to 28. Participants rated OM's safety 4.9 out of 5. The practice appears safe for traumatized populations and may reduce PTSD symptoms, warranting further research.